I agree that this site is using cookies. You can find further informations here.
X
Duhoux, F.P.
151  results:
Search for persons X
?
1

4MO Neoadjuvant letrozole and palbociclib versus chemothera..:

Cottu, P.H. ; Kieffer, Y. ; Lemonnier, J....
ESMO Open.  9 (2024)  - p. 103014 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Unravelling tumor heterogeneity in patients with HER2-low h..:

Fimereli, D. ; Serra, M. ; Rediti, M....
European Journal of Cancer.  200 (2024)  - p. 113834 , 2024
Link: https://doi.org/10.1016/..
 
?
3

59P Tumor cells-adipocytes interactions are associated with..:

Serra, M. ; Occelli, N. ; Rediti, M....
ESMO Open.  8 (2023)  1 - p. 101283 , 2023
Link: https://doi.org/10.1016/..
 
?
4

34P Investigating morphological heterogeneity in luminal br..:

Occelli, N. ; Serra, M. ; Rediti, M....
ESMO Open.  8 (2023)  1 - p. 101258 , 2023
Link: https://doi.org/10.1016/..
 
?
5

178P Dynamics of breast cancer T cell repertoire during neo..:

Birchall, C. ; Merhi, A. ; Devaux, A....
Immuno-Oncology and Technology.  20 (2023)  - p. 100637 , 2023
Link: https://doi.org/10.1016/..
 
?
6

255TiP AIPAC-003: A randomized, double-blind, placebo-contr..:

Duhoux, F.P. ; Ibrahim, N.K. ; Papadamitriou, K....
ESMO Open.  8 (2023)  1 - p. 101443 , 2023
Link: https://doi.org/10.1016/..
 
?
7

131P Efficacy of neoadjuvant letrozole and palbociclib in H..:

Frenel, J.S. ; Vincent-Salomon, A. ; Lemonnier, J....
ESMO Open.  8 (2023)  1 - p. 101470 , 2023
Link: https://doi.org/10.1016/..
 
?
8

186O Patient-reported outcomes (PROs) from DESTINY-Breast02..:

Fehm, T.N. ; Cottone, F. ; Dunton, K....
ESMO Open.  8 (2023)  1 - p. 101375 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Efficacy of olaparib in advanced cancers with germline or s..:

Joris, S. ; Denys, H. ; Collignon, J....
ESMO Open.  8 (2023)  6 - p. 102041 , 2023
Link: https://doi.org/10.1016/..
 
?
10

219P Spatial sequencing of T cell repertoire in breast canc..:

Merhi, A. ; Rosmaninho, P. ; Bar, I....
Immuno-Oncology and Technology.  16 (2022)  - p. 100330 , 2022
Link: https://doi.org/10.1016/..
 
?
11

PRECISION: the Belgian molecular profiling program of metas..:

Thouvenin, J. ; Van Marcke, C. ; Decoster, L....
ESMO Open.  7 (2022)  4 - p. 100524 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Impact of the line of treatment on progression-free surviva..:

Migeotte, A. ; Dufour, V. ; van Maanen, A....
BMC Cancer.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
13

Safety of systemic anti-cancer treatment in oncology patien..:

van Marcke, C. ; Honoré, N. ; van der Elst, A....
BMC Cancer.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
14

Assessment of potential process quality indicators for syst..:

van Walle, L. ; Punie, K. ; Van Eycken, E....
ESMO Open.  6 (2021)  4 - p. 100207 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Safety of assisted reproductive techniques in young women h..:

Condorelli, M. ; Bruzzone, M. ; Ceppi, M....
ESMO Open.  6 (2021)  6 - p. 100300 , 2021
Link: https://doi.org/10.1016/..
 
1-15